About the Authors
Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Information Services Division, NHS National Services Scotland, Edinburgh, United Kingdom
Department of Obstetrics and Gynaecology, National Institute for Health Research Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom
GCSS is a member of the Editorial Board of PLOS Medicine. GCSS has acted as a paid consultant to GSK around therapeutic approaches to preterm birth. GCSS is named on a US patent (US61/253936) for the administration of paraoxonase 3 to preterm human infants as a therapeutic product. The authors have declared there are no other competing interests.
Conceived and designed the experiments: GCSS. Performed the experiments: COW AMW GCSS. Analyzed the data: COW AMW GCSS. Contributed reagents/materials/analysis tools: COW MF KM AMW GCSS. Wrote the first draft of the manuscript: COW GCSS. Contributed to the writing of the manuscript: COW MF KM AMW GCSS. ICMJE criteria for authorship read and met: COW MF KM AMW GCSS. Agree with manuscript results and conclusions: COW MF KM AMW GCSS. Performed record linkage and selected data for analysis: MF KM.